ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

ANTX AN2 Therapeutics Inc

2.38
0.06 (2.59%)
최종 업데이트: 04:39:38
15분 지연
기업명 주식 심볼 시장 주식 타입
AN2 Therapeutics Inc ANTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.06 2.59% 2.38 04:39:38
개장가 저가 고가 종가 전일 종가
2.34 2.34 2.44 2.32
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
29/03/202405:10BWAN2 Therapeutics Reports Fourth Quarter and Full Year 2023..
14/02/202407:11EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/02/202421:01EDGAR2Form 8-K - Current report
12/02/202420:45BWAN2 to Voluntarily Pause Enrollment in Phase 3 Part of Phase..
31/01/202406:10BWAN2 Therapeutics to Present at Oppenheimer Healthcare Life..
19/01/202408:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/01/202407:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/01/202407:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202409:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202406:45EDGAR2Form 144 - Report of proposed sale of securities
03/01/202406:36EDGAR2Form 144 - Report of proposed sale of securities
17/11/202308:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:10EDGAR2Form 8-K - Current report
10/11/202306:05BWAN2 Therapeutics Reports Third Quarter 2023 Financial..
06/11/202321:00BWAN2 Therapeutics to Present at Upcoming Investor Conferences
18/10/202320:00BWAN2 Therapeutics Signs License Agreement with the University..
11/10/202313:01BWAN2 Therapeutics to Present New Data for Epetraborole at..
04/10/202308:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202305:10EDGAR2Form 144 - Report of proposed sale of securities
30/09/202306:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/09/202305:11EDGAR2Form 144 - Report of proposed sale of securities
26/09/202320:00BWAN2 Therapeutics Signs Grant Agreement to Discover Novel,..
16/09/202306:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/09/202321:00EDGAR2Form 8-K - Current report
13/09/202320:00BWAN2 Therapeutics commences Phase 3 Part of Phase 2/3..
09/09/202305:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/08/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/08/202305:14EDGAR2Form 144 - Report of proposed sale of securities
17/08/202305:50EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/08/202305:47EDGAR2Form 8-K - Current report
16/08/202311:42BWAN2 Therapeutics Announces Pricing of $70.0 Million..
11/08/202305:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202305:18EDGAR2Form 8-K - Current report
11/08/202305:10BWAN2 Therapeutics Reports Second Quarter 2023 Financial..
26/05/202305:10BWAN2 Therapeutics to Present at Jefferies Healthcare..
12/05/202305:10BWAN2 Therapeutics Reports First Quarter 2023 Financial..
01/05/202320:00BWAN2 Therapeutics to Present at JMP Securities Life Sciences..

최근 히스토리

Delayed Upgrade Clock